Leni van Doorn

Leni van Doorn is a Researcher at Erasmus MC, specializing in Rehabilitation Medicine. Her work bridges pharmacology, oncology, and clinical informatics.

Research interests include pharmacokinetics, chemotherapy protocols, and clinical outcome prediction in cancer treatment. Recent studies focus on paclitaxel premedication, esophageal cancer survival, and machine learning for patient monitoring.

The latest articles highlight her expertise in:

• Pharmacokinetic modeling of drug interactions
• Optimizing chemotherapy safety protocols
• Digital health applications for cancer prognosis